)
Dishman Pharmaceuticals and Chemicals today reported 18.59% dip in consolidated net profit at Rs 23.81 crore for the first quarter ended June 30, 2014-15.
It had posted net profit of Rs 29.25 crore for the April- June quarter of 2013-14, Dishman in a filing to the BSE.
Consolidated net sales of the company rose to Rs 361.55 crore for Q1, 2014-15 as against Rs 306.24 crore for the same period a year ago.
In a separate filing on the BSE, the company said its "Board has approved the proposal by way of passing an enabling resolution for issue of shares to Qualified Institutional Investors (QIP) up to Rs 200 crore, subject to approval of members."
The board has appointed Global CEO Mark Griffiths as an additional director of the company w.E.F. September 01, 2014, it added.
The Dishman scrip closed at Rs 128.25, down sharply by 12.61%, on the BSE.
